Retisert .59 mg/1
Fluocinolone Acetonide · IMPLANT · Bausch & Lomb Incorporated
Retisert is a implant containing fluocinolone acetonide at .59 mg/1, taken intravitreal. Manufactured by Bausch & Lomb Incorporated.
Key Facts
- Brand Name
- Retisert
- Generic Name
- Fluocinolone Acetonide
- NDC Code (Product)
24208-416- Manufacturer
- Bausch & Lomb Incorporated
- Strength
- .59 mg/1
- Dosage Form
- IMPLANT
- Route
- INTRAVITREAL
- Marketing Status
- Application #
- NDA021737
- Drug Class
- Corticosteroid [EPC]
- Marketing Start
- 04/08/2005
Recall History
No Recall HistoryFrequently Asked Questions
What is Retisert used for?
Retisert contains Fluocinolone Acetonide. It is a implant taken intravitreal. Consult your doctor for specific uses.
Is Retisert a controlled substance?
Retisert is not classified as a controlled substance by the DEA.
What is the generic name for Retisert?
The generic name for Retisert is Fluocinolone Acetonide. There are 12 other brand versions of Fluocinolone Acetonide.
What is the NDC code for Retisert .59 mg/1?
The NDC (National Drug Code) for Retisert .59 mg/1 is 24208-416, listed by Bausch & Lomb Incorporated.
Product NDC
24208-416
Other Fluocinolone Brands
See all →- Fluocinolone Acetonide.11 mg/mL72162-2321
- Flac Otic Oil.11 mg/mL39328-079
- Synalar.25 mg/g43538-900
- Fluocinolone Acetonide.11 mg/118.28mL51672-1356
- DERMOTIC.11 mg/mL68791-103
- fluocinolone acetonide.01 mg/100mL63629-8655
- FLUOCINOLONE ACETONIDE Oil.11 mg/mL64980-330
- Fluocinolone Acetonide.1 mg/mL43386-069
- fluocinolone acetonide.1 mg/g62559-288
- Fluocinolone Acetonide Oil.11 mg/mL64980-331
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)